Heterotopic ossification in systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 38, Issue 4, 2009, Pages 317-319

  Botzoris, V G ^a   Argyropoulou, M I ^b   Voulgari, P V ^a   Zikou, A K ^b   Drosos, A A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; PARACETAMOL; RISEDRONIC ACID;

ADULT; ARTICLE; CALCIFICATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FUNCTIONAL DISEASE; GENERAL CONDITION IMPROVEMENT; GLUTEUS MAXIMUS MUSCLE; HETEROTOPIC OSSIFICATION; HUMAN; JOINT EFFUSION; JOINT STIFFNESS; KNEE; MALE; MYOPATHY; OSSIFICATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS; THERAPY EFFECT; THIGH; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACETAMINOPHEN; COLCHICINE; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PAIN MEASUREMENT; PROGNOSIS; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; THIGH; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70350676634     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740902776919     Document Type: Article

References (26)

1. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23: 581-590
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205
3. TemekonidisTI,DrososAA. Subcutaneous calcification on the nose in a patient with scleroderma. Clin Exp Rheumatol 2001;19:560.
4. Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: The role of the disease and body composition. Scand J Rheumatol 2006;35:384-387
5. Bolster NB, Silver RM. Clinical features of systemic sclerosis. In: HochbergMC,SilmanAJ,SmolenJS, WeinblattME,WeismanMH, editors. Rheumatology, 4th edn. Mosby, 2008;1375-1385
6. Fujii N, Hamano T, Isaka Y, Ito T, Imai E. Risedronate: A possible treatment for extraosseous calcification. Clin Calcium 2005;15(Suppl 1):75-78; discussion 78-79
7. Kaplan FS, Glaser Dl, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004;12:116-125
8. Sugita A, Hashimoto J, Maeda A, Kobayashi J, Hirao M, Masuhara K, et al. Heterotopic ossification in bilateral knee and hip joints after long-term sedation. J Bone Miner Metab 2005;23:329-332
9. Pape HC, Lehmann U, Van Griensven M, Gansslen A, Von Glinski S, Krettek C. Heterotopic ossifications in patients after severe blunt trauma with and without head trauma: Incidence and patterns of distribution. J Orthop Trauma 2001;15:229-237
10. Jacobs JW, De Sonnaville PB, Hulsmans HM, van Rinsum AC, Bijlsma JW. Polyarticular heterotopic ossification complicating critical illness. Rheumatology (Oxford) 1999;38:1145-1149
11. Argyropoulou MI, Kostandi E, Kosta P, Zikou AK, Kastani D, Galiatsou E, et al. Heterotopic ossification of the knee joint in intensive care unit patients: Early diagnosis with magnetic resonance imaging. Crit Care 2006;10:R152.
12. Takahashi S, Kanetake J, Kanawaku Y, Funayama M. Adult autopsy case with marked myositis ossificans: Association with repetitive physical assault and battery. Leg Med (Tokyo) 2008;10:274-276
13. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002;43:346-353
14. Olmstead-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 2007;170:620-632
15. Arends JE, Drillenburg P, van der Woude HJ, Roozendaal KJ, de Valk B. [Non-traumatic myositis ossificans circumscripta in the teres major muscle], in Dutch. Ned Tijdschr Geneeskd 2003;147:768-771
16. Ajike SO, Mohammed A, Adebayo ET, Ononiwu CN, Omisakin OO. Myositis ossificans circumscripta of the supraorbital region: A case report. Ann Afr Med 2007;6:203-206
17. De Maeseneer M, Jaovisidha S, Lenchik L, Vaughan LM, Russack V, Sartoris DJ, et al. Myositis ossificans of the foot. J Foot Ankle Surg 1997;36:290-3; discussion 331.
18. Rosenberg AE. Pseudosarcomas of soft tissue. Arch Pathol Lab Med 2008;132:579-586
19. Kransdorf MJ, Meis JM. From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremeties. Radiographics 1993;13:853-884
20. Fonseca JE, Branco JC, Reis J, Evangelista T, Tavares V, Gomes AR, et al. Fibrodysplasia ossificans progressiva: Report of two cases. Clin Exp Rheumatol 2000;18:749-752
21. Kaplan FS, LeMerrerM, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008;22:191-205.
22. Futani H, Okayama A, Maruo S, Kinoshita G, Ishikura R. The role of imaging modalities in the diagnosis of primary dedifferentiated parosteal osteosarcoma. J Orthop Sci 2001;6:290-294
23. BenHamidaKS, HajriR,KedadiH, BouhaoualaH, SalahMH, Mestiri A, et al. Myositis ossificans circumscripta of the knee improved by alendronate. Joint Bone Spine 2004;71:144-146 (Pubitemid 38407224)
24. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kö lbl O. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg Br 1997;79:596-602.
25. Fuchs D, Fruchter L, Fishel B, Holtzman M, Yaron M.Colchicine suppressionof localinflammationduetocalcinosisindermatomyositis and progressive systemic sclerosis. ClinRheumatol 1986;5:527-530
26. Voulgari PV, Zikou AK, Drosos AA. Subcutaneous lesions in dermatomyositis. Rheumatology (Oxford) 2006;45:165.